Egg Freezing and Embryo Banking Market - By Service Type, By Storage Duration, By Technology, By Application, By Age Group- Global Forecast, 2026 - 2035

Egg Freezing and Embryo Banking Market Size

The global egg freezing and embryo banking market was valued at USD 5.1 billion in 2025 and is projected to grow from USD 5.6 billion in 2026 to USD 13.6 billion by 2035, expanding at a CAGR of 10.3%, according to the latest report published by Global Market Insights Inc. This considerable growth is driven by numerous factors such as growing awareness and acceptance of fertility preservation options among women and couples, advancements in cryopreservation techniques, rising global infertility rates, and increasing number of fertility clinics and partnerships.

Egg freezing and embryo storage are methods of preserving reproductive potential, allowing people or couples to prepare for the future birth of children. In the case of oocyte cryopreservation (egg freezing), an egg is taken from a healthy female before she becomes pregnant and frozen so that it is ready for later use. Embryo banking refers to the storage of embryos made by taking an egg and sperm and growing it to the stage of being an embryo through the use of in vitro fertilization (IVF) before it is frozen. Each technique uses modern cryopreservation processes, such as vitrification, to maximize the chances of successful recovery from freezing. Egg freezing and embryo banking are becoming more common among women who are delaying childbirth because of personal choices, health issues, or professional obligations. Increasing numbers of employers and clinics now provide assistance with these procedures. Some leading companies in the egg freezing and embryo banking industry include IVIRMA Global, Monash IVF Group, Boston IVF, CCRM Fertility, and Genea Pty Limited.
 

The market grew from USD 4 billion in 2022 to USD 4.7 billion in 2024. Rising global infertility rates is a pivotal demand driver for egg freezing and embryo banking, as more individuals and couples seek proactive options to preserve reproductive potential while dealing with biological, lifestyle, and medical challenges. According to the World Health Organization (WHO, 2023), infertility affects approximately 17.5% of adults worldwide, equivalent to one in six individuals. The prevalence remains consistent across income levels, with 17.8% in high-income countries and 16.5% in low- and middle-income nations. Overall, an estimated 42 to 180 million people globally are impacted by infertility, creating a significant care gap and increasing demand for solutions like egg freezing and embryo storage. These services now cater not only to patients with medical needs but also to healthy individuals delaying parenthood, driving long-term growth and wider adoption through employer and insurance support.
 

Additionally, the rapid expansion of fertility clinics worldwide is significantly improving access to egg freezing and embryo banking services. According to the CDC, the U.S. had 457 reporting fertility clinics in 2022, performing over 184,000 egg and embryo-banking cycles. This growing infrastructure enables broader geographic coverage and shorter wait times, making fertility preservation more accessible. Additionally, strategic partnerships between clinics, employers, and insurance providers are reducing financial barriers and normalizing these services as part of reproductive care. Together, these developments are driving sustained market growth and enhancing patient adoption globally.
 

Embryo banking and egg freezing are two different techniques used to store one's fertility for the future. Egg freezing refers to when a woman collects and freezes her eggs, whereas embryo banking refers to the storage of embryos that are made by fertilizing the stored eggs with sperm. Both of these methods are important for individuals who wish to delay their pregnancy for personal, medical, or career reasons and for people who are undergoing treatments that could impair future fertility. Individuals can preserve their eggs or embryos, thus giving themselves a greater chance of becoming a biological parent later in life.

Egg Freezing and Embryo Banking Market Trends

• Advancements in cryopreservation techniques have become a critical driver for the egg freezing and embryo banking industry, significantly improving survival rates, reducing ice crystal formation, and enhancing overall reliability of fertility preservation.
   
• These innovations have enabled a shift from traditional slow freezing methods to ultra-rapid vitrification, which prevents ice crystal damage and achieves post-thaw survival rates of up to 90%, making it the global standard for oocyte and embryo storage.
   
• A cornerstone of this evolution is the development of automated vitrification platforms that standardize processes and minimize operator variability. For instance, Overture Life’s DaVitri system automates vitrification steps, ensuring consistency and scalability for fertility clinics.
   
• Innovations in cryoprotectants have focused on reducing toxicity and improving cell viability. Modern vitrification solutions combine permeating CPAs like ethylene glycol (EG) and dimethyl sulfoxide (DMSO) with non-permeating agents such as sucrose or trehalose. Trehalose-based media have shown superior outcomes, with studies reporting higher implantation rates and improved embryo quality compared to sucrose-based solutions. Additionally, macromolecules like hydroxypropyl cellulose (HPC) and human serum albumin (HSA) are now included to buffer osmotic stress and enhance protection.
   
• Together, these technologies support delayed parenthood, improve IVF success rates, and strengthen the role of fertility preservation in personalized reproductive care, therefore increasing market growth.
   

Egg Freezing and Embryo Banking Market Analysis

Based on service type, the market is divided into egg freezing and embryo banking. The global market was estimated at USD 5.1 billion in 2025. The embryo banking segment held revenues of USD 3 billion in the year 2025 and the segment poised for significant growth at a CAGR of 10.2% during the forecast period.
 

• Embryo banking enables the long-term storage of embryos created through IVF, offering individuals and couples viable future conception options. Unlike egg freezing, embryo preservation completes fertilization and embryonic development before freezing, increasing the likelihood of successful implantation and live birth. It is commonly utilized by those pursuing delayed parenthood, individuals facing medical treatments that threaten fertility, and donor embryo programs.
   
• This segment plays a dominant role within the egg freezing and embryo banking market, supported by strong utilization trends. In the UK, the Human Fertilisation and Embryology Authority (HFEA) reported a 30% rise in embryo storage cycles between 2019 and 2021 across 107 licensed clinics, demonstrating growing acceptance and uptake.
   
• Ongoing technological advances and increasing infertility rates underscore its strategic importance. Improvements in cryopreservation such as vitrification, optimized cryoprotectants, and advanced carrier tools have elevated survival and viability outcomes.
   
• As a result of rising demand, proven clinical success, and continuous technological innovation, the embryo banking segment remains a key growth driver in the market.
   

Based on storage duration, the egg freezing and embryo banking market is bifurcated into short-term storage and long-term storage. The short-term storage segment held a market share of 67% in 2025 and the market is predicted to grow at 10.2% CAGR during the forecast period.
 

• Short-term storage in the egg freezing and embryo banking industry typically refers to preservation periods ranging from a few months to up to one year. This option is primarily chosen by individuals undergoing fertility treatments or medical procedures that require temporary preservation of gametes or embryos.
   
• The demand for short-term storage is driven by factors such as immediate fertility treatments, planned in-vitro fertilization (IVF) cycles, and medical interventions like chemotherapy that temporarily affect reproductive health.
   
• Advancements in cryopreservation techniques, including vitrification, have enhanced the viability of eggs and embryos during short-term storage. Fertility clinics are increasingly offering flexible storage packages, integrated monitoring systems, and secure cryogenic facilities to ensure optimal conditions.
   
• The combination of cost-effectiveness, technological advancements, and rising demand for immediate fertility solutions is expected to accelerate adoption, thereby driving overall market growth in the coming years.
   

Based on technology, the egg freezing and embryo banking market is bifurcated into vitrification and slow freezing. The vitrification segment is growing robustly, with a 10.4% CAGR during the forecast period.
 

• The vitrification segment represents a rapid cryopreservation technique that converts eggs and embryos into a glass-like state without forming ice crystals. This method significantly reduces cellular damage and improves post-thaw survival rates compared to traditional slow-freezing approaches, making it the preferred choice in modern fertility preservation.
   
• The adoption of vitrification is driven by its superior clinical outcomes. According to First fertility PGS center, oocyte survival rates with vitrification range between 92 % and 97 %, compared to approximately 30 % with slow-freezing methods. These high success rates have encouraged fertility clinics and patients to opt for vitrification, particularly in elective egg freezing and IVF cycles, where reliability and efficiency are critical.
   
• To enhance vitrification processes, fertility centers are investing in advanced cryoprotectant formulations, automated freezing systems, and integrated monitoring technologies.
   
• The proven efficiency of vitrification, combined with rising demand for fertility preservation and technological advancements, is creating strong growth opportunities for the market.
   

Based on application, the egg freezing and embryo banking market is segmented into fertility preservation, donor egg/embryo programs, genetic screening, and oncofertility. The fertility preservatin segment accounted for a share of 30.8% in 2025 and is expected to grow at a CAGR of 10.2% during the forecast period.
 

• The fertility preservation segment has gained prominence as global fertility rates continue to decline. According to World Population Prospects 2024, the global fertility rate currently stands at 2.25 live births per woman, down from 3.31 in 1990, highlighting a significant demographic shift. This trend has increased awareness about preserving reproductive potential, especially among individuals delaying parenthood.
   
• Medical conditions and treatments such as chemotherapy, radiation, and surgeries often compromise fertility, creating a strong need for preservation techniques. Options like oocyte and embryo cryopreservation are widely adopted to ensure patients retain the possibility of biological parenthood despite health challenges.
   
• Lifestyle changes and socio-economic factors further drive demand. With more individuals prioritizing careers and postponing childbirth, fertility preservation offers a proactive solution to counter age-related decline. Supportive regulations and growing acceptance of assisted reproductive technologies have accelerated adoption globally.
   
• By addressing medical and lifestyle challenges, this segment is fueling growth in the egg freezing and embryo banking industry and strengthening its role in modern reproductive healthcare.
   

Based on age group, the egg freezing and embryo banking market is segmented into under 30, 31 to 40, and over 41. The 31 to 40 segment accounted for a share of 45.6% in 2025.
 

• The age group 31–40 years represents a critical demographic for fertility preservation, as reproductive potential declines significantly during this period. Women in this bracket often seek preservation for elective reasons such as career planning or due to medical conditions that may impair fertility.
   
• According to the Global Burden of Disease Study (GBD) 2021, 110 million women and 55 million men aged 15–49 experienced infertility globally, equating to prevalence rates of 3.7% in women (3,713 per 100,000) and 1.8% in men (1,821 per 100,000). Infertility risk accelerates after age 30, making timely intervention essential for individuals in this segment.
   
• Fertility preservation techniques such as oocyte and embryo cryopreservation are widely adopted for this age group. These methods help mitigate age-related decline and ensure future reproductive options, supported by advancements in cryogenic technology and improved clinical protocols.
• The rising prevalence of infertility and lifestyle trends like delayed parenthood have positioned the 31–40 age group as a major driver of market growth.
   

North America Egg Freezing and Embryo Banking Market

North America dominated the global egg freezing and embryo banking industry with a market share of 42.6% in 2025.

North America represents one of the most advanced and rapidly expanding markets for egg freezing and embryo banking, driven by high awareness, robust clinical infrastructure, and supportive regulatory frameworks. The U.S. market was valued at USD 1.5 billion and USD 1.7 billion in 2022 and 2023, respectively. The market size reached USD 2 billion in 2025, growing from USD 1.8 billion in 2024In the U.S., assisted reproductive technology (ART) utilization continues to rise as individuals increasingly delay parenthood for career and lifestyle reasons. According to CDC data for 2022, there were 435,426 ART cycles performed on 251,542 unique patients at 457 reporting U.S. clinics, resulting in 94,039 live-birth deliveries and 98,289 live-born infants, which accounted for approximately 2.6% of all infants born in the country. This strong adoption reflects growing confidence in fertility preservation technologies and their role in family planning.Egg and embryo banking cycles form a substantial portion of ART procedures in the region. Of the ART cycles reported to the CDC in 2022, 184,423 were egg or embryo banking cycles, where all resulting eggs or embryos were frozen for future use. This trend highlights the increasing preference for deferred childbearing and proactive fertility management among women in their 30s and early 40s. The combination of advanced cryopreservation techniques, insurance coverage improvements, and rising demand for elective fertility preservation is fueling market growth in North America.
 

Europe Egg Freezing and Embryo Banking Market

Europe market accounted for USD 881.2 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Europe is a dominant region in the egg freezing and embryo banking industry, driven by advanced reproductive technologies and strong regulatory frameworks. According to ESHRE’s European IVF Monitoring (EIM) consortium, 41 European countries collectively reported more than 923,318 ART treatment cycles in 2020, reflecting the region’s high adoption of assisted reproductive techniques. This extensive activity underscores the growing importance of fertility preservation as individuals increasingly delay parenthood for lifestyle and career reasons.
   
• Within these cycles, 4,895 were frozen oocyte replacement cycles, highlighting the rising preference for egg and embryo banking across Europe. The combination of technological innovation, improved cryopreservation success rates, and supportive healthcare policies is fueling market growth in Europe.
   

Germany egg freezing and embryo banking market is projected to experience steady growth between 2026 and 2035.
 

• Germany is witnessing a notable rise in egg freezing and embryo banking, driven by increasing awareness and demand for fertility preservation. According to the 2024 IVF Register published in Deutsches Ärzteblatt, 1,808 individuals froze their eggs in 2022, increasing to 2,755 in 2023, marking a significant upward trend. The average age for egg freezing is around 35 years, with the highest uptake among women aged 30–37, reflecting lifestyle changes and delayed parenthood.
   
• This surge in adoption highlights Germany’s growing role in the European fertility preservation market. Advancements in cryopreservation technology, coupled with broader social acceptance of elective fertility preservation, are fueling market growth and positioning Germany as a key contributor to regional expansion.
   

Asia Pacific Egg Freezing and Embryo Banking Market

The Asia Pacific region is projected to be valued at USD 1.7 billion in 2025.
 

• The Asia-Pacific market is witnessing robust growth, driven by increasing awareness and acceptance of fertility preservation among women and couples. Rising social openness toward assisted reproductive technologies, coupled with changing lifestyle patterns and delayed parenthood trends, has amplified demand for advanced solutions. Educational campaigns and supportive healthcare policies across countries like Japan, India, and Australia are further encouraging individuals to explore options such as egg freezing and embryo banking.
   
• Advancements in cryopreservation techniques have significantly enhanced the success rates of fertility preservation procedures, making them more reliable and accessible. Innovations in vitrification and storage protocols have improved the viability of oocytes and embryos, reducing risks associated with long-term preservation. These technological improvements, combined with expanding fertility clinics and growing investment in reproductive health infrastructure, position Asia-Pacific as a key growth region for infertility treatment services.
   

Japan egg freezing and embryo banking market is poised to witness lucrative growth between 2026 - 2035.

• Japan’s market is expanding steadily, supported by growing awareness and acceptance of fertility preservation among women and couples. Cultural shifts toward delayed parenthood, combined with rapid aging, declining marriage rates, and later childbearing trends, have significantly impacted fertility levels. According to the Ministry of Health, Labour and Welfare, Japan’s fertility rate fell to 1.33 in 2020, down from the previous record low of 1.36 in 2019, underscoring the urgency for advanced reproductive solutions. These demographic challenges are fueling demand for options such as egg freezing and embryo banking.
   
• Technological advancements in cryopreservation techniques have strengthened Japan’s position as a leader in fertility care. Improved vitrification methods and enhanced storage protocols have boosted success rates, making fertility preservation more reliable and appealing. Combined with a strong network of specialized clinics and continuous investment in reproductive technologies, these factors are expected to sustain market growth in the coming years.
   

Latin America Egg Freezing and Embryo Banking Market

• Brazil’s market is witnessing strong growth, driven by profound demographic changes and evolving family planning trends. In 1960, the country’s Total Fertility Rate (TFR) was 6.28 children per woman, reaching 8.56 in the North Region. By 2022, according to the Brazilian Census, this rate declined sharply to 1.55 nationally and 1.89 in the North Region, reflecting delayed parenthood, urbanization, and lifestyle shifts. These factors have increased interest in fertility preservation solutions among women and couples seeking to extend their reproductive window.
   
• Recent progress in cryopreservation technology has transformed the reliability of long-term storage. Cutting-edge vitrification methods now deliver superior survival rates for oocytes and embryos, reducing risks and improving clinical outcomes. Alongside these innovations, Brazil is witnessing a surge in fertility clinics, targeted awareness programs, and private sector investment in assisted reproduction. These factors collectively position the Brazil as a strategic growth hub for fertility preservation services in Latin America.
   

Middle East and Africa Egg Freezing and Embryo Banking Market

The egg freezing and embryo banking industry in Saudi Arabia is expected to experience significant and promising growth from 2026 to 2035.
 

• Saudi Arabia’s market is gaining traction as the country experiences a surge in fertility clinics and strategic partnerships. Rising demand for advanced reproductive solutions, coupled with growing awareness among women and couples, is encouraging healthcare providers to expand their service offerings. Collaborations between local clinics and international fertility centers are improving access to cutting-edge technologies and specialized expertise, making fertility preservation more widely available.
   
• These developments are supported by increasing investment in healthcare infrastructure and a strong focus on modernizing reproductive care. Partnerships are enabling the introduction of advanced cryopreservation techniques, which enhance the success rates of egg and embryo storage. With a rapidly evolving healthcare ecosystem and growing acceptance of assisted reproductive technologies, Saudi Arabia is emerging as a promising market for fertility preservation services in the Middle East.
   

Egg Freezing and Embryo Banking Market Share

• The leading companies in the egg freezing and embryo banking industry include IVIRMA Global, Monash IVF Group, Boston IVF, CCRM Fertility, and Genea Pty Limited, collectively accounting for a 45% market share of the global market.
   
• These players dominate through extensive networks of fertility clinics, advanced cryopreservation technologies, and strong expertise in assisted reproductive services.
   
• Market leadership is reinforced by continuous innovation in vitrification techniques, personalized treatment protocols, and integrated digital platforms for patient engagement. For example, IVIRMA Global offers cutting-edge vitrification solutions combined with genetic screening services to optimize embryo viability and success rates.
   
• Expansion strategies focus on geographic penetration and strategic partnerships. Leading players are actively entering emerging markets in Asia-Pacific and the Middle East, leveraging collaborations with hospitals and telehealth platforms to broaden access to fertility preservation services.
   
• Technology integration remains a key differentiator. Companies are investing in AI-driven embryo selection tools, advanced storage monitoring systems, and patient-centric mobile applications to enhance clinical outcomes and improve user experience.
   
• By combining technological advancements, global reach, and collaborative models, these players are positioning themselves for sustained growth in the market. Their focus on innovation and accessibility aligns with rising demand for fertility preservation worldwide.
   

Egg Freezing and Embryo Banking Market Companies

Few of the prominent players operating in the egg freezing and embryo banking industry include:

• Boston IVF
• Carrot
• CCRM Fertility
• Cryos International
• Extend Fertility
• Genea Pty Limited
• IVIRMA
• Monash IVF Group
• New Hope IVF & Fertility Clinic
• Ovation Fertility
• Progyny
• ReproTech
• RMA Network
• Shady Grove Fertility
• Spring Fertility
• WINFertility

IVIRMA Global

IVIRMA Global is one of the world’s largest fertility networks, operating over 200 clinics across 15 countries. The company specializes in advanced egg freezing and embryo banking services using cutting-edge vitrification techniques to ensure high survival rates of oocytes and embryos. IVIRMA integrates genetic screening and time-lapse incubator technology to optimize embryo development and improve success rates. Their global presence and research-driven approach make them a leader in fertility preservation solutions.
 

Monash IVF Group

Monash IVF Group is a pioneer in fertility preservation, credited with achieving the world’s first live birth from a vitrified oocyte. The group offers comprehensive egg freezing and embryo banking services across Australia and Singapore, using advanced cryopreservation protocols to maintain egg quality. Monash IVF emphasizes personalized care, providing fertility preservation options for women delaying parenthood or undergoing medical treatments. Their strong clinical expertise and innovation in vitrification technology position them as a trusted name in the Asia-Pacific region.
 

Boston IVF

Boston IVF is a leading U.S. fertility clinic network with over 25 locations, offering one of the most robust egg freezing programs in the country. The clinic has seen a six-fold increase in egg freezing procedures, performing over 5,000 cycles annually. Boston IVF provides specialized services for oncofertility patients and transgender individuals, ensuring timely and efficient preservation through its Fast Track program. The clinic also integrates advanced cryostorage technologies and automation through partnerships like TMRW Life Sciences, reinforcing its leadership in fertility care.
 

Egg Freezing and Embryo Banking Industry News

• In November 2023, Spanish investment firm GED Capital and fertility group IVIRMA Global acquired the Barcelona-based fertility business Eugin Group in a deal valued at up to EUR 500 million (USD 558.4 million), including earn-outs. This acquisition enabled IVIRMA Global to further its expansion into the North American market.
   
• In June 2021, Boston IVF, a fertility clinic with over 25 locations across the U.S., announced a partnership with TMRW Life Sciences, Inc. to introduce innovative technology and automation to its cryostorage and fertility cell management practices. This integration of TMRW's groundbreaking innovations exemplifies Boston IVF's ongoing leadership in reproductive medicine. The partnership is expected to enhance operational efficiency, improve the accuracy of cryopreservation processes, and further solidify the clinic's position at the forefront of fertility treatment advancements.
   

The egg freezing and embryo banking market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Service Type

• Egg freezing
• Embryo banking

Market, By Storage Duration

• Short-term storage
• Long-term storage

Market, By Technology

• Vitrification
• Slow freezing

Market, By Application

• Fertility preservation
• Donor egg/embryo programs
• Genetic screening
• Oncofertility

Market, By Age Group

• Under 30
• 31 to 40
• Over 41

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE